Back to Search
Start Over
JPM23: With preclinical gene writing data on display, Tessera CEO's spirits not dampened by California's wild weather.
- Source :
- FierceBiotech; 1/17/2023, pN.PAG-N.PAG, 1p
- Publication Year :
- 2023
-
Abstract
- At the J.P. Morgan Healthcare Conference, Tessera demonstrated that its technology worked in primate models of PKU, sickle cell disease and more. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- Database :
- Complementary Index
- Journal :
- FierceBiotech
- Publication Type :
- Periodical
- Accession number :
- 161363565